Logo image of 1BDX.MI

BECTON DICKINSON AND CO (1BDX.MI) Stock Fundamental Analysis

Europe - BIT:1BDX - US0758871091 - Common Stock

156.7 EUR
-8.05 (-4.89%)
Last: 10/30/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, 1BDX scores 5 out of 10 in our fundamental rating. 1BDX was compared to 60 industry peers in the Health Care Equipment & Supplies industry. 1BDX has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1BDX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1BDX had positive earnings in the past year.
1BDX had a positive operating cash flow in the past year.
Each year in the past 5 years 1BDX has been profitable.
1BDX had a positive operating cash flow in each of the past 5 years.
1BDX.MI Yearly Net Income VS EBIT VS OCF VS FCF1BDX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

1BDX has a Return On Assets of 3.03%. This is comparable to the rest of the industry: 1BDX outperforms 48.33% of its industry peers.
1BDX has a Return On Equity of 6.61%. This is comparable to the rest of the industry: 1BDX outperforms 53.33% of its industry peers.
The Return On Invested Capital of 1BDX (5.61%) is comparable to the rest of the industry.
1BDX had an Average Return On Invested Capital over the past 3 years of 5.35%. This is below the industry average of 8.99%.
The 3 year average ROIC (5.35%) for 1BDX is below the current ROIC(5.61%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROIC 5.61%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.35%
ROIC(5y)5.07%
1BDX.MI Yearly ROA, ROE, ROIC1BDX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

The Profit Margin of 1BDX (7.68%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of 1BDX has grown nicely.
1BDX has a better Operating Margin (13.86%) than 70.00% of its industry peers.
In the last couple of years the Operating Margin of 1BDX has grown nicely.
1BDX has a Gross Margin of 45.44%. This is in the lower half of the industry: 1BDX underperforms 61.67% of its industry peers.
In the last couple of years the Gross Margin of 1BDX has remained more or less at the same level.
Industry RankSector Rank
OM 13.86%
PM (TTM) 7.68%
GM 45.44%
OM growth 3Y-0.5%
OM growth 5Y7.2%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y-0.11%
GM growth 5Y0.46%
1BDX.MI Yearly Profit, Operating, Gross Margins1BDX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1BDX is destroying value.
1BDX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1BDX has less shares outstanding
Compared to 1 year ago, 1BDX has an improved debt to assets ratio.
1BDX.MI Yearly Shares Outstanding1BDX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
1BDX.MI Yearly Total Debt VS Total Assets1BDX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.2 Solvency

The Debt to FCF ratio of 1BDX is 7.18, which is on the high side as it means it would take 1BDX, 7.18 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.18, 1BDX is in line with its industry, outperforming 48.33% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that 1BDX is somewhat dependend on debt financing.
1BDX has a worse Debt to Equity ratio (0.69) than 78.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 7.18
Altman-Z N/A
ROIC/WACC0.76
WACC7.41%
1BDX.MI Yearly LT Debt VS Equity VS FCF1BDX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

1BDX has a Current Ratio of 1.11. This is a normal value and indicates that 1BDX is financially healthy and should not expect problems in meeting its short term obligations.
1BDX's Current ratio of 1.11 is on the low side compared to the rest of the industry. 1BDX is outperformed by 71.67% of its industry peers.
1BDX has a Quick Ratio of 1.11. This is a bad value and indicates that 1BDX is not financially healthy enough and could expect problems in meeting its short term obligations.
1BDX has a worse Quick ratio (0.64) than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.64
1BDX.MI Yearly Current Assets VS Current Liabilites1BDX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. Growth

3.1 Past

1BDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.57%, which is quite good.
1BDX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.19% yearly.
1BDX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.23%.
The Revenue has been growing slightly by 6.32% on average over the past years.
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%

3.2 Future

Based on estimates for the next years, 1BDX will show a small growth in Earnings Per Share. The EPS will grow by 7.66% on average per year.
Based on estimates for the next years, 1BDX will show a small growth in Revenue. The Revenue will grow by 4.00% on average per year.
EPS Next Y3.94%
EPS Next 2Y5.8%
EPS Next 3Y6.96%
EPS Next 5Y7.66%
Revenue Next Year4.3%
Revenue Next 2Y4.35%
Revenue Next 3Y4.14%
Revenue Next 5Y4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1BDX.MI Yearly Revenue VS Estimates1BDX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
1BDX.MI Yearly EPS VS Estimates1BDX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.57 indicates a correct valuation of 1BDX.
Compared to the rest of the industry, the Price/Earnings ratio of 1BDX indicates a rather cheap valuation: 1BDX is cheaper than 93.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, 1BDX is valued rather cheaply.
1BDX is valuated correctly with a Price/Forward Earnings ratio of 12.09.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1BDX indicates a somewhat cheap valuation: 1BDX is cheaper than 80.00% of the companies listed in the same industry.
1BDX is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.57
Fwd PE 12.09
1BDX.MI Price Earnings VS Forward Price Earnings1BDX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

1BDX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1BDX is cheaper than 70.00% of the companies in the same industry.
76.67% of the companies in the same industry are more expensive than 1BDX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 19.45
EV/EBITDA 12.83
1BDX.MI Per share data1BDX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1BDX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.19
PEG (5Y)1.75
EPS Next 2Y5.8%
EPS Next 3Y6.96%

5

5. Dividend

5.1 Amount

1BDX has a Yearly Dividend Yield of 2.37%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.37, 1BDX pays a better dividend. On top of this 1BDX pays more dividend than 81.67% of the companies listed in the same industry.
1BDX's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.37%

5.2 History

The dividend of 1BDX has a limited annual growth rate of 0.75%.
Dividend Growth(5Y)0.75%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

71.28% of the earnings are spent on dividend by 1BDX. This is not a sustainable payout ratio.
The dividend of 1BDX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP71.28%
EPS Next 2Y5.8%
EPS Next 3Y6.96%
1BDX.MI Yearly Income VS Free CF VS Dividend1BDX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
1BDX.MI Dividend Payout.1BDX.MI Dividend Payout, showing the Payout Ratio.1BDX.MI Dividend Payout.PayoutRetained Earnings

BECTON DICKINSON AND CO

BIT:1BDX (10/30/2025, 7:00:00 PM)

156.7

-8.05 (-4.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-03 2026-02-03
Inst Owners92.24%
Inst Owner ChangeN/A
Ins Owners0.57%
Ins Owner ChangeN/A
Market Cap44.91B
Revenue(TTM)21.84B
Net Income(TTM)1.68B
Analysts72.63
Price Target190.9 (21.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.37%
Yearly Dividend3.28
Dividend Growth(5Y)0.75%
DP71.28%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.54%
Min EPS beat(2)-0.05%
Max EPS beat(2)7.13%
EPS beat(4)3
Avg EPS beat(4)5.56%
Min EPS beat(4)-0.05%
Max EPS beat(4)14.05%
EPS beat(8)7
Avg EPS beat(8)5.42%
EPS beat(12)10
Avg EPS beat(12)4.67%
EPS beat(16)13
Avg EPS beat(16)5.77%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.22%
Max Revenue beat(2)-0.58%
Revenue beat(4)1
Avg Revenue beat(4)-0.99%
Min Revenue beat(4)-2.51%
Max Revenue beat(4)0.37%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)-0.54%
Revenue beat(16)6
Avg Revenue beat(16)-0.54%
PT rev (1m)3.81%
PT rev (3m)3.81%
EPS NQ rev (1m)-12.54%
EPS NQ rev (3m)-12.54%
EPS NY rev (1m)1.31%
EPS NY rev (3m)1.31%
Revenue NQ rev (1m)-4.56%
Revenue NQ rev (3m)-4.56%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 12.57
Fwd PE 12.09
P/S 2.38
P/FCF 19.45
P/OCF 15.14
P/B 2.05
P/tB N/A
EV/EBITDA 12.83
EPS(TTM)12.47
EY7.96%
EPS(NY)12.96
Fwd EY8.27%
FCF(TTM)8.06
FCFY5.14%
OCF(TTM)10.35
OCFY6.61%
SpS65.9
BVpS76.62
TBVpS-32.07
PEG (NY)3.19
PEG (5Y)1.75
Graham Number146.62
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 6.61%
ROCE 6.44%
ROIC 5.61%
ROICexc 5.69%
ROICexgc 25.49%
OM 13.86%
PM (TTM) 7.68%
GM 45.44%
FCFM 12.23%
ROA(3y)2.9%
ROA(5y)3.12%
ROE(3y)6.24%
ROE(5y)6.77%
ROIC(3y)5.35%
ROIC(5y)5.07%
ROICexc(3y)5.52%
ROICexc(5y)5.23%
ROICexgc(3y)26.44%
ROICexgc(5y)26.65%
ROCE(3y)6.16%
ROCE(5y)5.84%
ROICexgc growth 3Y-6.54%
ROICexgc growth 5Y8%
ROICexc growth 3Y2.92%
ROICexc growth 5Y13.47%
OM growth 3Y-0.5%
OM growth 5Y7.2%
PM growth 3Y-4.96%
PM growth 5Y10%
GM growth 3Y-0.11%
GM growth 5Y0.46%
F-Score7
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 7.18
Debt/EBITDA 3.21
Cap/Depr 30.87%
Cap/Sales 3.48%
Interest Coverage 250
Cash Conversion 62.49%
Profit Quality 159.12%
Current Ratio 1.11
Quick Ratio 0.64
Altman-Z N/A
F-Score7
WACC7.41%
ROIC/WACC0.76
Cap/Depr(3y)33.59%
Cap/Depr(5y)39.6%
Cap/Sales(3y)3.86%
Cap/Sales(5y)4.6%
Profit Quality(3y)162.63%
Profit Quality(5y)151.73%
High Growth Momentum
Growth
EPS 1Y (TTM)9.57%
EPS 3Y5.64%
EPS 5Y7.19%
EPS Q2Q%3.94%
EPS Next Y3.94%
EPS Next 2Y5.8%
EPS Next 3Y6.96%
EPS Next 5Y7.66%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y4.99%
Revenue growth 5Y6.32%
Sales Q2Q%8.33%
Revenue Next Year4.3%
Revenue Next 2Y4.35%
Revenue Next 3Y4.14%
Revenue Next 5Y4%
EBIT growth 1Y4.74%
EBIT growth 3Y4.47%
EBIT growth 5Y13.98%
EBIT Next Year22.48%
EBIT Next 3Y13.08%
EBIT Next 5Y12.3%
FCF growth 1Y-13.11%
FCF growth 3Y17.14%
FCF growth 5Y-0.73%
OCF growth 1Y-9.69%
OCF growth 3Y9.2%
OCF growth 5Y-0.62%

BECTON DICKINSON AND CO / 1BDX.MI FAQ

Can you provide the ChartMill fundamental rating for BECTON DICKINSON AND CO?

ChartMill assigns a fundamental rating of 5 / 10 to 1BDX.MI.


What is the valuation status of BECTON DICKINSON AND CO (1BDX.MI) stock?

ChartMill assigns a valuation rating of 6 / 10 to BECTON DICKINSON AND CO (1BDX.MI). This can be considered as Fairly Valued.


How profitable is BECTON DICKINSON AND CO (1BDX.MI) stock?

BECTON DICKINSON AND CO (1BDX.MI) has a profitability rating of 6 / 10.


How financially healthy is BECTON DICKINSON AND CO?

The financial health rating of BECTON DICKINSON AND CO (1BDX.MI) is 3 / 10.


What is the expected EPS growth for BECTON DICKINSON AND CO (1BDX.MI) stock?

The Earnings per Share (EPS) of BECTON DICKINSON AND CO (1BDX.MI) is expected to grow by 3.94% in the next year.